Keywords: واکسن HIV; HIV vaccine; Vaccine trial; Risk compensation; HVTN 505; Behavioral disinhibition; Ad5+;
مقالات ISI واکسن HIV (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن HIV; HIV transmission; HIV vaccine; Structural sensitivity analysis; Inference robustness assessment; Network model; Dynamic compartmental model; PWID; people who inject drugs; MSM; men who have sex with men; PWUD; people who abuse but do not inject drugs; HIV
Keywords: واکسن HIV; Feline immunodeficiency virus; Human immunodeficiency virus; Vaccine protective rate; Vaccine effectiveness; FIV vaccine; HIV vaccine; Cats;
Keywords: واکسن HIV; HIV vaccine; Willingness-to-pay; Conjoint analysis; Discrete choice; Thailand;
HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine
Keywords: واکسن HIV; HIV vaccine; Mathematical model; South Africa; HIV prevention;
Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity
Keywords: واکسن HIV; HIV vaccine; Nef; Adjuvant; Prime-boost strategy; Hsp27; Hp91;
Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization
Keywords: واکسن HIV; CD4bs; CD4 binding site; CFA; Complete Freund's Adjuvant; IFA; Incomplete Freund's Adjuvant; mAb; monoclonal antibody; gp120; V3; HIV vaccine; Immunofocusing; Neutralizing antibodies;
Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system
Keywords: واکسن HIV; Vaccinia virus TianTan; Replication-competent viral vector; HSV-1 thymidine kinase/ganciclovir; Suicide gene system; HIV vaccine;
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides
Keywords: واکسن HIV; HIV-1; HIV vaccine; HIV-1 neutralizing antibodies; V3 immunogens; Non-human primates immunization; Rhesus macaque immunoglobulin genes;
Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV
Keywords: واکسن HIV; T cell activation; HIV vaccine; DNA-MVA; Poxvirus; HIV risk;
The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation
Keywords: واکسن HIV; DNA vaccine; Electroporation; Delivery site; Tumor vaccine; HIV vaccine;
Factors influencing frontline health service providersʼ likelihood to recommend a future, preventive HIV vaccine to key populations in Karnataka, south India
Keywords: واکسن HIV; HIV vaccine; Vaccine acceptability; Key populations; India; Karnataka;
Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques
Keywords: واکسن HIV; Live attenuated viral vector; Rubella vaccine strain RA27/3; Rhesus macaque; SIV Gag; De novo cellular responses; Recall cellular responses; Memory T cells; Cytotoxic T cells; DNA vaccine; CM9 tetramer response; IFN-γ response; HIV vaccine; DNA prime rub
Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides
Keywords: واکسن HIV; Liposome; Adjuvant; HIV vaccine; Lipid membrane; MPER; Nanoparticle;
Socioeconomic status and HIV vaccine preparedness studies in North America
Keywords: واکسن HIV; HIV vaccine; Socioeconomic status; Willingness to participate; Retention;
Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus
Keywords: واکسن HIV; HIV vaccine; SHIV-C; Heterologous tier 2 virus; Rhesus monkey; Cellular immunity; ADCC;
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques
Keywords: واکسن HIV; HIV vaccine; HIV CD4i epitope; Rhesus macaque model; Replication-competent Ad; Systemic and mucosal adaptive immunity; Memory B and T cells; Antibody-dependent cellular cytotoxicity; Neutralizing antibody;
Successful vaccination of immune suppressed recipients using Listeria vector HIV-1 vaccines in helminth infected mice
Keywords: واکسن HIV; SEA; soluble egg antigens from Schistosoma mansoni; Chronic helminth infection; Endemic schistosomiasis; Vaccine efficacy; HIV vaccine; Listeria monocytogenes;
Nanomedicine applications towards the cure of HIV
Keywords: واکسن HIV; HIV vaccine; HIV eradication; Memory T cells; Drug development
Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques
Keywords: واکسن HIV; HIV vaccine; HIV Tat; HIV Envelope; Rhesus macaque; SHIV challenge; ADCC
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform
Keywords: واکسن HIV; HIV vaccine; Ad5 immunity; Adenovirus vector; SIVmac239; Ad5 [E1-, E2b-];
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses
Keywords: واکسن HIV; Immunogenicity; Dose; MVA; Fowlpoxvirus; HIV vaccine; Prime-boost;
Development of an immunoassay for differentiating human immunodeficiency virus infections — from vaccine-induced immune response in Tiantan vaccine trials in China
Keywords: واکسن HIV; HIV vaccine; HIV infections; Differential diagnosis; Rapid Flow-through Test
Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer
Keywords: واکسن HIV; VLP; Electroporation; Electrotransfer; HIV vaccine; DNA vaccine
A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge
Keywords: واکسن HIV; rAd5; recombinant Adenovirus serotype 5; Mamu; Macaca mulatta; PCR-SSP; PCR amplification with sequence-specific primers; QRT-PCR; quantitative reverse transcription-PCR; HIV vaccine; Adenovirus serotype 5; Simian immunodeficiency virus; CD8+ T cells; CD4
Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine
Keywords: واکسن HIV; DNA vaccine; TNF superfamily ligand; HIV vaccine
Vaccine-induced HIV seropositivity: A problem on the rise
Keywords: واکسن HIV; HIV vaccine; HIV serodiagnosis; HIV seropositivity; HIV antibodies; HIV diagnostic tests; Vaccine-induced seropositivity
Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia
Keywords: واکسن HIV; HIV vaccine; MSM; Australia; Individual-based; Mathematical model
Selectively willing and conditionally able: HIV vaccine trial participation among women at “high risk” of HIV infection
Keywords: واکسن HIV; HIV vaccine; Research subject recruitment; Willingness to participate; African American women; Crack cocaine users; Qualitative research
The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: Examining the RV144 trial results
Keywords: واکسن HIV; HIV vaccine; Mathematical model; HIV prevention; South Africa; Combination prevention
The potential impact of RV144-like vaccines in rural South Africa: A study using the STDSIM microsimulation model
Keywords: واکسن HIV; HIV vaccine; Mathematical model; Microsimulation model; South Africa; Cost-effectiveness
Preparing for the availability of a partially effective HIV vaccine: Some lessons from other licensed vaccines
Keywords: واکسن HIV; HIV vaccine; Hepatitis B vaccine; HPV vaccine; Influenza vaccine; Annual strain selection; Program implementation;
Conceptual framework for behavioral and social science in HIV vaccine clinical research
Keywords: واکسن HIV; HIV vaccine; Behavioral social science; Conceptual framework; Clinical trial;
Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: A Phase I safety study
Keywords: واکسن HIV; Therapeutic immunization; HIV vaccine; Uganda;
Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine
Keywords: واکسن HIV; HIV vaccine; Ad5 immunity; Adenovirus vector; Ad5 [E1-, E2b-];
The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand
Keywords: واکسن HIV; HIV vaccine; Mathematical model; HIV prevention; South Africa; Thailand; Combination prevention
Socioecological influences on community involvement in HIV vaccine research
Keywords: واکسن HIV; HIV/AIDS; HIV vaccine; Socioecological model; Community engagement; Willingness to participate; Recruitment
Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccine
Keywords: واکسن HIV; HIV vaccine; Feline immunodeficiency virus; T-cell epitopes
The cost-effectiveness of a modestly effective HIV vaccine in the United States
Keywords: واکسن HIV; HIV vaccine; Cost-effectiveness analysis; Mathematical model
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania
Keywords: واکسن HIV; HIV vaccine; DNA prime; MVA boost;
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003
Keywords: واکسن HIV; HIV infection; Heroin; Methamphetamine; Asia; HIV vaccine
Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men
Keywords: واکسن HIV; Willingness to participate; HIV vaccine; Chinese MSM
Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand
Keywords: واکسن HIV; HIV vaccine; Men who have sex with men; Vaccine-induced seropositivity; Risk compensation; Thailand;
Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys
Keywords: واکسن HIV; HIV vaccine; CD4+ T cell responses; Rhesus monkey; SHIV-89.6P
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans
Keywords: واکسن HIV; HIV vaccine; Rhesus monkey; Human; IFN-γ ELISPOT;
Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus
Keywords: واکسن HIV; HIV vaccine; Biodegradable nanoparticles; Adjuvant;
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold
Keywords: واکسن HIV; Immunogen design; HIV-1; gp120; V3 loop; Cholera toxin B subunit; Neutralizing antibody; 447-52D; HIV vaccine;
Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys
Keywords: واکسن HIV; HIV vaccine; Immune balance; Immune breadth; Protection; SIVmac239
Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV
Keywords: واکسن HIV; HIV vaccine; Virus-like particle; Dendritic cells; CD40 ligand
AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection
Keywords: واکسن HIV; AIDSVax; Vaxgen; HIV Vaccine; T cell;